Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction
Abstract Background Sugammadex, a γ-cyclodextrin derivative, belongs to a new class of selective relaxant binding agents. Sugammadex was approved 10-years ago by the European medicines agency and today is used in clinical anesthesia and emergency medicine globally. In this review, indications for ne...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2018-11-01
|
| Seri Bilgileri: | BMC Anesthesiology |
| Konular: | |
| Online Erişim: | http://link.springer.com/article/10.1186/s12871-018-0605-6 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|